Search Results - "Reguero, J"

Refine Results
  1. 1

    ECG as a part of the preparticipation screening programme: an old and still present international dilemma by Hevia, A Carro, Fernández, M M, Palacio, J M A, Martín, E H, Castro, M G, Reguero, J J Rodríguez

    Published in British journal of sports medicine (01-08-2011)
    “…Long-term Italian experience has provided evidence that preparticipation screening in competitive athletes with 12-lead ECG, history and physical examination…”
    Get more information
    Journal Article
  2. 2
  3. 3
  4. 4

    Reversible pre-capillary pulmonary hypertension due to dasatinib by Buchelli Ramirez, Herminia L, Álvarez Álvarez, Celso M, Rodríguez Reguero, José J, García Clemente, Marta M, Casan Clarà, Pere

    Published in Respiratory care (01-05-2014)
    “…Pulmonary arterial hypertension and secondary pleural effusion have been reported in association with long-term therapy with the multi-tyrosine kinase…”
    Get full text
    Journal Article
  5. 5

    Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction by González, P, Alvarez, R, Batalla, A, Reguero, J R, Alvarez, V, Astudillo, A, Cubero, G I, Cortina, A, Coto, E

    Published in Genes and immunity (01-06-2001)
    “…Our objective was to examine the association between myocardial infarction (MI) and two DNA-polymorphisms at the proinflammatory chemokine receptors CCR2…”
    Get full text
    Journal Article
  6. 6

    The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction by González, P, García-Castro, M, Reguero, J R, Batalla, A, Ordóñez, A G, Palop, R L, Lozano, I, Montes, M, Álvarez, V, Coto, E

    Published in Journal of medical genetics (01-02-2006)
    “…Background: A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has…”
    Get full text
    Journal Article
  7. 7

    Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms : association with early coronary disease by ALVAREZ, R, REGUERO, J. R, BATALLA, A, IGLESIAS-CUBERO, G, CORTINA, A, ALVAREZ, V, COTO, E

    Published in Cardiovascular research (01-11-1998)
    “…To examine the association between coronary artery disease and polymorphisms at the angiotensin-converting enzyme (ACE) and angiotensin II type 1 receptor…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A functional Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene is not associated with myocardial infarction by González, P., Reguero, J. R., Lozano, I., Morís, C., Coto, E.

    Published in International journal of immunogenetics (01-04-2007)
    “…Summary Arachidonate 5‐lipoxygenase is an enzyme encoded by the ALOX5 gene, and plays an important role in the synthesis of leukotrienes. These are…”
    Get full text
    Journal Article
  10. 10

    ABCA1 polymorphisms and prognosis after myocardial infarction in young patients by Martín, María, González, Pelayo, Reguero, J.J.R., Batalla, Alberto, García Castro, Mónica, Coto, Eliecer, Morís, César

    Published in International journal of cardiology (16-06-2006)
    “…High-density cholesterol (HDL) levels are affected by genetic influences and certain behaviors. Low levels of HDL-C are considered as an independent risk…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Screening of the endothelin1 gene (EDN1) in a cohort of patients with essential left ventricular hypertrophy by Castro, M. G., Rodríguez‐Pascual, F., Magán‐Marchal, N., Reguero, J. R., Alonso‐Montes, C., Morís, C., Alvarez, V., Lamas, S., Coto, E.

    Published in Annals of human genetics (01-09-2007)
    “…Summary Our objective was to analyse the role of endothelin1 gene (EDN1) variation in essential left ventricular hypertrophy (LVH). We searched for EDN1…”
    Get full text
    Journal Article
  13. 13
  14. 14

    A search for cyclophilin-A gene (PPIA) variation and its contribution to the risk of atherosclerosis and myocardial infarction by Palacín, M., Rodríguez, I., García-Castro, M., Ortega, F., Reguero, J. R., López-Larrea, C., Morís, C., Alvarez, V., Coto, E.

    Published in International journal of immunogenetics (01-04-2008)
    “…Summary Cyclophilin A is secreted by vascular smooth muscle cells in response to inflammatory stimuli, and could thus contribute to atherosclerosis. We…”
    Get full text
    Journal Article
  15. 15

    Familial restrictive cardiomyopathy with atrioventricular block without skeletal myopathy by Cubero, Gustavo Iglesias, Larraya, Gary Lasa, Reguero, J Rodríguez

    “…Familial restrictive cardiomyopathy is an autosomal dominant cardiomyopathy histologically characterized by myocyte hypertrophy and interstitial fibrosis. The…”
    Get full text
    Journal Article
  16. 16

    Left ventricular mass index and sports: the influence of different sports activities and arterial blood pressure by Iglesias Cubero, G., Batalla, A., Rodriguez Reguero, J.J., Barriales, R., González, V., de la Iglesia, J.L., Terrados, N.

    Published in International journal of cardiology (15-09-2000)
    “…Background: The mechanisms by which endurance training produces physiological hypertrophy have been thoroughly investigated but not with young athletes. The…”
    Get full text
    Journal Article
  17. 17

    Restrictive cardiomyopathy caused by chloroquine by Iglesias Cubero, G, Rodriguez Reguero, J J, Rojo Ortega, J M

    Published in British Heart Journal (01-05-1993)
    “…A 59 year old white woman who had been treated with chloroquine phosphate for 25 years presented with signs of congestive heart failure and was diagnosed as…”
    Get full text
    Journal Article
  18. 18

    Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults by Fernandez, Maria Martin, Rodriguez Reguero, J.J., González, Pelayo

    “…No relationship existed between ACE group polymorphism and clinical evolution, but patients with two- and three-vessel disease were mostly DD (p < 0.01)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    170. Cirugía de la miocardiopatía hipertrófica obstructiva: resultados a medio plazo by Álvarez, R, Hernández, D, Díaz, R, Barral, A, Morales, C, Naya, J.L, Reguero, J, Llosa, J.C

    Published in Cirugía cardiovascular (01-04-2012)
    “…La miocardiopatía hipertrófica obstructiva (MHO) afecta a 1 de 500 personas. El tratamiento quirúrgico ha demostrado ser efectivo en supervivencia y mejoría…”
    Get full text
    Journal Article